Sign up to save your podcasts
Or
Share VMAT2 Inhibitors: Valbenazine (Ingrezza) and Deutetrabenazine (Austedo)
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
VMAT2 Inhibitors: Valbenazine (Ingrezza) and Deutetrabenazine (Austedo)
Welcome back! Today we are featuring the two FDA-approved medications for tardive dyskinesia, the VMAT2 inhibitors Valbenazine (Ingrezza) and Deutetrabenazine (Austedo).
References:
https://pubmed.ncbi.nlm.nih.gov/41626799/
https://www.ncbi.nlm.nih.gov/books/NBK548187/
https://pubmed.ncbi.nlm.nih.gov/41626799/
View all episodes
By Dr. Tanner Hewitt, Dr. Larry Wang and Dr. Bradley Miller
4.8
147147 ratings
Welcome back! Today we are featuring the two FDA-approved medications for tardive dyskinesia, the VMAT2 inhibitors Valbenazine (Ingrezza) and Deutetrabenazine (Austedo).
References:
https://pubmed.ncbi.nlm.nih.gov/41626799/
https://www.ncbi.nlm.nih.gov/books/NBK548187/
https://pubmed.ncbi.nlm.nih.gov/41626799/
More shows like PsychRounds: The Psychiatry Podcast
View all
ADHD Experts Podcast
1,332 Listeners
NEI Podcast
137 Listeners
The Curbsiders Internal Medicine Podcast
3,369 Listeners
PsychEd: Educational Psychiatry Podcast
157 Listeners
Psychiatry & Psychotherapy Podcast
1,361 Listeners
Real Life Pharmacology - Pharmacology Education for Health Care Professionals
729 Listeners
Psychopharmacology and Psychiatry Updates
293 Listeners
Inside Schizophrenia
209 Listeners
The Carlat Psychiatry Podcast
560 Listeners
Back from the Abyss: Psychiatry in Stories
489 Listeners
Psychology Unplugged
756 Listeners
Inside Bipolar
261 Listeners
Psychiatry Boot Camp
199 Listeners
Psychiatry Unboxed with TheKicksShrink
5 Listeners
This Is Your Brain On Drugs Psychiatry Podcast
20 Listeners